Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
$8.23B |
| 2 |
Chipotle Mexican Grill
CMG
|
$251M |
| 3 |
Exxon Mobil
XOM
|
$151M |
| 4 |
GE Vernova
GEV
|
$139M |
| 5 |
Amphenol
APH
|
$119M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$184M |
| 2 |
Apple
AAPL
|
$117M |
| 3 |
Microsoft
MSFT
|
$110M |
| 4 |
Meta Platforms (Facebook)
META
|
$80.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$58.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Preformed Line Products
PLPC
$927M
| $604K | ﹤0.01% |
4,853
-600
| -11% | -$74.7K |
|
2377
Alector
ALEC
$272M
| $599K | ﹤0.01% |
131,900
| – | – |
|
2378
Applied Optoelectronics
AAOI
$1.43B
| $595K | ﹤0.01% |
71,800
-9,200
| -11% | -$76.3K |
|
|
CBL
2379
CBL Properties
CBL
$962M
| $594K | ﹤0.01% |
25,400
+3,300
| +15% | +$77.2K |
|
|
ENFN
2380
DELISTED
Enfusion, Inc.
ENFN
| $594K | ﹤0.01% |
69,700
| – | – |
|
2381
Savara
SVRA
$582M
| $592K | ﹤0.01% |
147,000
| – | – |
|
2382
Fate Therapeutics
FATE
$115M
| $587K | ﹤0.01% |
+179,100
| New | +$587K |
|
2383
B. Riley Financial
RILY
$167M
| $586K | ﹤0.01% |
33,200
| – | – |
|
2384
HBT Financial
HBT
$820M
| $578K | ﹤0.01% |
28,300
| – | – |
|
2385
Phathom Pharmaceuticals
PHAT
$848M
| $577K | ﹤0.01% |
56,000
| – | – |
|
2386
Bally's
BALY
$486M
| $571K | ﹤0.01% |
47,725
-10,800
| -18% | -$129K |
|
2387
FuelCell Energy
FCEL
$92.3M
| $571K | ﹤0.01% |
894,000
| – | – |
|
2388
KRONOS Worldwide
KRO
$703M
| $570K | ﹤0.01% |
45,400
| – | – |
|
2389
1-800-Flowers.com
FLWS
$348M
| $566K | ﹤0.01% |
59,500
| – | – |
|
2390
Montauk Renewables
MNTK
$300M
| $564K | ﹤0.01% |
99,000
| – | – |
|
2391
Definitive Healthcare
DH
$401M
| $564K | ﹤0.01% |
103,300
| – | – |
|
2392
Designer Brands
DBI
$197M
| $563K | ﹤0.01% |
82,400
| – | – |
|
|
VERV
2393
DELISTED
Verve Therapeutics
VERV
| $562K | ﹤0.01% |
115,100
+11,900
| +12% | +$58.1K |
|
2394
ARS Pharmaceuticals
SPRY
$1.08B
| $562K | ﹤0.01% |
66,000
| – | – |
|
|
CLCO
2395
Cool Company
CLCO
$402M
| $559K | ﹤0.01% |
47,888
| – | – |
|
2396
Seneca Foods Class A
SENEA
$773M
| $557K | ﹤0.01% |
9,700
| – | – |
|
|
FNA
2397
DELISTED
Paragon 28, Inc.
FNA
| $557K | ﹤0.01% |
81,400
+8,000
| +11% | +$54.7K |
|
2398
Ranpak Holdings
PACK
$397M
| $555K | ﹤0.01% |
86,300
| – | – |
|
|
AMPS
2399
DELISTED
Altus Power, Inc.
AMPS
| $555K | ﹤0.01% |
141,500
+16,200
| +13% | +$63.5K |
|
2400
HilleVax
HLVX
$104M
| $552K | ﹤0.01% |
38,200
| – | – |
|